De-risk your biggest strategic decisions with our most comprehensive market data and projections (worldwide sales, share by supplier, CAGRs) on 27 major market segments and 200+ sub-segments, prepared with consistent methodologies and forecast periods.
Write a comment ...
Most medtech innovations fail—but they don’t have to. In Predictable Winners, Ilya Trakhtenberg and Stuart Jackson of L.E.K. Consulting offer a proven, step-by-step framework to improve your odds. Drawing on decades of real-world experience, the authors reveal how medtech companies can systematically de-risk innovation, forecast smarter, execute better, and build enduring franchises. This isn’t theory—it’s a tactical guide for founders, operators, and leaders navigating a high-stakes landscape. From concept to commercialization and beyond, discover how to turn your breakthrough idea into a market-defining success story. Because success isn’t luck—it’s learnable.
The medtech industry trends of 2025 are redefining healthcare delivery with AI-powered diagnostics, wearable monitoring devices, robotics, and minimally invasive surgical systems. Learn how these innovations are driving efficiency, reducing costs, and improving patient experiences. This overview highlights breakthrough technologies, investment hotspots, and market shifts that will influence healthcare providers, investors, and patients in the years ahead. Stay informed on the future of medical technology and how industry leaders are adapting to meet global health challenges.
Brain-computer interfaces (BCIs) are rapidly evolving in medtech, advancing into clinical trials. Synchron, led by CEO Thomas Oxley, pioneers an endovascular BCI, avoiding open brain surgery. Backed by investors like Gates and Bezos, Synchron aims to restore autonomy for paralyzed patients. Inspired by interventional cardiology, Synchron's approach is shaping a new frontier in neurotechnology, merging biomedical innovation with real-world applications.
Eduardo Fonseca leads XCath and EndoQuest Robotics, both revolutionizing robotic surgery and endovascular interventions. XCath pioneers remote stroke treatment with intracranial robotics, while EndoQuest develops scar-free flexible surgery. Both spun out from UT’s Microsurgical Robotics Lab and are advancing through pivotal trials. Fonseca will present at LSI USA ‘25, showcasing innovations that could redefine surgical and stroke care worldwide. Join us in Dana Point this March.
At LSI Europe ’24, Dr. Catherine Mohr—President of the Intuitive Foundation and former VP of Strategy at Intuitive Surgical—delivered a powerful keynote on solving healthcare’s most complex, “wicked problems.” She traced the evolution of Intuitive’s surgical robotics, including the 29-year journey to the da Vinci system and the launch of the Ion platform for lung cancer diagnosis. Mohr’s message: innovation must close the gap between clinical need and what technology enables. Now focused on global surgical training and access, she urges the medtech industry to rethink education, AI integration, and healthcare delivery on a worldwide scale.
The medical device industry is undergoing a seismic shift with AI-driven innovation transforming healthcare. Industry leaders Alex Gorsky and Rick Anderson stress that stakeholders must adapt or risk obsolescence. The rapid rise of AI, changing funding models, and evolving partnerships will redefine medtech. Those embracing new technologies will drive the next generation of healthcare.
Our specialized in-house team has decades of experience evaluating medtech markets and executing custom projects for emerging companies, corporate strategics, consulting and private equity firms, investment banks, and more. Our syndicated market intelligence platform is built by in-house medtech insiders for global medtech executives, with coverage across all medtech markets in all major domestic and global geographies.
Write a comment ...